INTERPHARM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
INTERPHARM
Largest movements
No asset line moved by more than 1% of the balance sheet total.
- Profit (loss) carried forward -€3,030
down €3,030 (-2.4%), from -€126,422 to -€129,452
- Other debts +€2,297
up €2,297 (+4.9%), from €46,698 to €48,995
- Trade debts +€1,276
new in 2025: €1,276
- Short-term financial debts -€392
down €392 (-0.5%), from €75,392 to €75,000
- Gross operating margin +€664
up €664 (+24.1%), from -€2,757 to -€2,093
- Financial charges +€317
up €317 (+2115.3%), from €15 to €332
- Other operating charges -€295
down €295 (-32.8%), from €900 to €604
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €20,628 | €20,778 | +€150 | +0.7% |
| Current assets | 29/58 | €20,628 | €20,778 | +€150 | +0.7% |
| Amounts receivable within one year | 40/41 | €20,384 | €20,384 | = | 0.0% |
| Other amounts receivable | 41 | €20,384 | €20,384 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €243 | €394 | +€150 | +61.9% |
| Total equity and liabilities | 10/49 | €20,628 | €20,778 | +€150 | +0.7% |
| Equity | 10/15 | -€101,462 | -€104,492 | -€3,030 | -3.0% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €18,760 | €18,760 | = | 0.0% |
| Tax-exempt reserves | 132 | €16,900 | €16,900 | = | 0.0% |
| Distributable reserves | 133 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€126,422 | -€129,452 | -€3,030 | -2.4% |
| Amounts payable | 17/49 | €122,090 | €125,270 | +€3,181 | +2.6% |
| Amounts payable within one year | 42/48 | €122,090 | €125,270 | +€3,181 | +2.6% |
| Financial debts | 43 | €75,392 | €75,000 | -€392 | -0.5% |
| Credit institutions | 430/8 | €75,392 | €75,000 | -€392 | -0.5% |
| Trade debts | 44 | - | €1,276 | +€1,276 | |
| Suppliers | 440/4 | - | €1,276 | +€1,276 | |
| Other amounts payable | 47/48 | €46,698 | €48,995 | +€2,297 | +4.9% |
| Other operating charges | 640/8 | €900 | €604 | -€295 | -32.8% |
| Gross operating margin | 9900 | -€2,757 | -€2,093 | +€664 | +24.1% |
| Operating profit (loss) | 9901 | -€3,657 | -€2,698 | +€959 | +26.2% |
| Financial charges | 65/66B | €15 | €332 | +€317 | +2115.3% |
| Recurring financial charges | 65 | €15 | €332 | +€317 | +2115.3% |
| Profit (loss) for the period before taxes | 9903 | -€3,672 | -€3,030 | +€642 | +17.5% |
| Income taxes | 67/77 | €1 | - | -€1 | |
| Profit (loss) for the period | 9904 | -€3,673 | -€3,030 | +€643 | +17.5% |
| Profit (loss) for the period to be appropriated | 9905 | -€3,673 | -€3,030 | +€643 | +17.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.